PD-L1 amplification is rare in solid tumors, but responses to PD-1/PD-L1 blockade seen in patients with the amplification warrant testing for it...
Gadolinium-based contrast agents used for MRI will now carry a warning regarding potential retention in the bodies and brains of treated patients...
Bevacizumab-awwb is approved for the treatment of adults with certain colorectal, lung, brain, kidney, and cervical cancers.
Intensive, up-front treatment may help elderly patients with glioblastoma the most.
CHICAGO – For patients with asymptomatic brain metastases from melanoma who had not had prior treatment, nivolumab combined with ipilimumab...
Gleolan received FDA approval on June 7.
CHICAGO – A trend was observed in longer overall survival among those patients who received recommended treatments.
CHICAGO – Lead study investigator David Hyman, MD, discusses the integrated analysis of three larotrectinib trials and the drug’s regulatory...
Adding an immunostimulatory cytokine to CAR-T improved the adaptive immunotherapy’s activity against aggressive pediatric brain malignancies.
BOSTON – Primary site irradiation in children with medulloblastoma can be limited to the tumor bed rather than the whole posterior fossa.